Advertisement

Index by author

November 01, 1982; Volume 22,Issue 3

A

  1. Abita, J P

    1. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;

  2. Albuquerque, E X

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;
    2. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;

  3. Anderson, W

    1. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;

  4. Aslanian, D

    1. Inelastic electron tunneling spectroscopic study of interaction of acetylcholine and beta-methyl acetylcholine with alumina surface.
      D Aslanian and S de Cheveigné
      Molecular Pharmacology November 1982, 22 (3) 678-686;

B

  1. Barber, R

    1. Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;

  2. Bend, J R

    1. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;

  3. Boyd, M R

    1. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;

  4. Brown, O E

    1. Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;

  5. Brune, K

    1. Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
      E L Mehler, J Habicht and K Brune
      Molecular Pharmacology November 1982, 22 (3) 525-528;

  6. Burt, S

    1. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;

  7. Butcher, R W

    1. Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;

C

  1. Catterall, W A

    1. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow and W A Catterall
      Molecular Pharmacology November 1982, 22 (3) 627-635;

  2. Chwang, T L

    1. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;

  3. Clark, R B

    1. Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;

  4. Clement-Cormier, Y C

    1. Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
      E T Suen, P C Kwan and Y C Clement-Cormier
      Molecular Pharmacology November 1982, 22 (3) 595-601;

  5. Cohen, J B

    1. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;

  6. Collins, A C

    1. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
      M J Marks and A C Collins
      Molecular Pharmacology November 1982, 22 (3) 554-564;

  7. Cost, H

    1. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;

D

  1. Daly, J W

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

  2. Dannan, G A

    1. Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues.
      G A Dannan and F P Guengerich
      Molecular Pharmacology November 1982, 22 (3) 787-794;

  3. de Cheveigné, S

    1. Inelastic electron tunneling spectroscopic study of interaction of acetylcholine and beta-methyl acetylcholine with alumina surface.
      D Aslanian and S de Cheveigné
      Molecular Pharmacology November 1982, 22 (3) 678-686;

  4. De Lean, A

    1. Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;

E

  1. Eldefrawi, M E

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

F

  1. Franklin, P

    1. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;

G

  1. Gespach, C

    1. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;

  2. Goka, T J

    1. Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;

  3. Green, D A

    1. Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;

  4. Guengerich, F P

    1. Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues.
      G A Dannan and F P Guengerich
      Molecular Pharmacology November 1982, 22 (3) 787-794;

  5. Gylfe, E

    1. Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
      E Gylfe and B Hellman
      Molecular Pharmacology November 1982, 22 (3) 715-720;

H

  1. Habicht, J

    1. Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
      E L Mehler, J Habicht and K Brune
      Molecular Pharmacology November 1982, 22 (3) 525-528;

  2. Hamrell, M

    1. Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;

  3. Hashimoto, G

    1. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;

  4. Hellman, B

    1. Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
      E Gylfe and B Hellman
      Molecular Pharmacology November 1982, 22 (3) 715-720;

  5. Hnatowich, M

    1. Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea pig heart by the food dye erythrosine.
      M Hnatowich and F S LaBella
      Molecular Pharmacology November 1982, 22 (3) 687-692;

  6. Houghton, J A

    1. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
      J A Houghton, A J Tice and P J Houghton
      Molecular Pharmacology November 1982, 22 (3) 771-778;

  7. Houghton, P J

    1. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
      J A Houghton, A J Tice and P J Houghton
      Molecular Pharmacology November 1982, 22 (3) 771-778;

I

  1. Insel, P A

    1. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
      M D Snavely and P A Insel
      Molecular Pharmacology November 1982, 22 (3) 532-546;

J

  1. Jessup, P J

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

  2. Johnston, C I

    1. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
      E A Woodcock and C I Johnston
      Molecular Pharmacology November 1982, 22 (3) 589-594;

  3. Joost, H G

    1. Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte.
      H G Joost and H J Steinfelder
      Molecular Pharmacology November 1982, 22 (3) 614-618;

K

  1. Kaiser, E T

    1. Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
      J W Taylor, R J Miller and E T Kaiser
      Molecular Pharmacology November 1982, 22 (3) 657-666;

  2. Kloss, M W

    1. Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
      G M Rosen, M W Kloss and E J Rauckman
      Molecular Pharmacology November 1982, 22 (3) 529-531;

  3. Koivusaari, U

    1. Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;

  4. Kwan, P C

    1. Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
      E T Suen, P C Kwan and Y C Clement-Cormier
      Molecular Pharmacology November 1982, 22 (3) 595-601;

L

  1. LaBella, F S

    1. Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea pig heart by the food dye erythrosine.
      M Hnatowich and F S LaBella
      Molecular Pharmacology November 1982, 22 (3) 687-692;

  2. Lang, M

    1. Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;

  3. Laszlo, J

    1. Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;

  4. Lefkowitz, R J

    1. Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;

  5. Loew, G

    1. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;

  6. Lombardini, J B

    1. Differences in the active-site region of tumor versus normal isozymes of mammalian ATP:L-methionine S-adenosyltransferase.
      J R Sufrin and J B Lombardini
      Molecular Pharmacology November 1982, 22 (3) 752-759;

  7. Lucier, G W

    1. Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;

  8. Lui, E M

    1. Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;

  9. Lukovitz, I

    1. A theorem on de novo group contributions.
      I Lukovitz
      Molecular Pharmacology November 1982, 22 (3) 725-731;

M

  1. MacDonald, T L

    1. Rat liver microsomal metabolism of propyl halides.
      H Tachizawa, T L MacDonald and R A Neal
      Molecular Pharmacology November 1982, 22 (3) 745-751;

  2. Macfarlane, D E

    1. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
      D E Macfarlane and D C Stump
      Molecular Pharmacology November 1982, 22 (3) 574-579;
    2. Bidirectional collision coupling in the regulation of the adenylate cyclase. The allozyme hypothesis for receptor function.
      D E Macfarlane
      Molecular Pharmacology November 1982, 22 (3) 580-588;

  3. Mackenzie, P

    1. Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;

  4. Maleque, M A

    1. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;

  5. Marks, M J

    1. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
      M J Marks and A C Collins
      Molecular Pharmacology November 1982, 22 (3) 554-564;

  6. Mason, R P

    1. Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
      C Mottley, T B Trice and R P Mason
      Molecular Pharmacology November 1982, 22 (3) 732-737;

  7. McMenamin, M G

    1. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;

  8. Mehler, E L

    1. Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
      E L Mehler, J Habicht and K Brune
      Molecular Pharmacology November 1982, 22 (3) 525-528;

  9. Miller, R J

    1. Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
      J W Taylor, R J Miller and E T Kaiser
      Molecular Pharmacology November 1982, 22 (3) 657-666;

  10. Mottley, C

    1. Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
      C Mottley, T B Trice and R P Mason
      Molecular Pharmacology November 1982, 22 (3) 732-737;

N

  1. Neal, R A

    1. Rat liver microsomal metabolism of propyl halides.
      H Tachizawa, T L MacDonald and R A Neal
      Molecular Pharmacology November 1982, 22 (3) 745-751;

  2. Nebert, D W

    1. Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
      R H Tukey, M Negishi and D W Nebert
      Molecular Pharmacology November 1982, 22 (3) 779-786;

  3. Negishi, M

    1. Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
      R H Tukey, M Negishi and D W Nebert
      Molecular Pharmacology November 1982, 22 (3) 779-786;

  4. Nimit, Y

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

O

  1. Odom, G

    1. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;

  2. Overman, L E

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

P

  1. Peck, C

    1. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;

  2. Peura, P

    1. Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;

  3. Philpot, R M

    1. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
    2. Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;

R

  1. Rauckman, E J

    1. Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
      G M Rosen, M W Kloss and E J Rauckman
      Molecular Pharmacology November 1982, 22 (3) 529-531;

  2. Rautanen, P K

    1. Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.
      M M Vohra and P K Rautanen
      Molecular Pharmacology November 1982, 22 (3) 602-608;

  3. Retz, K C

    1. Mechanism of inhibition of protein synthesis by morphine in rat brain and liver.
      K C Retz and W J Steele
      Molecular Pharmacology November 1982, 22 (3) 706-714;

  4. Roberts, D

    1. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;

  5. Rosen, G M

    1. Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
      G M Rosen, M W Kloss and E J Rauckman
      Molecular Pharmacology November 1982, 22 (3) 529-531;

S

  1. Saal, F

    1. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;

  2. Sedwick, W D

    1. Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;

  3. Slaughter, S R

    1. Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;

  4. Snavely, M D

    1. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
      M D Snavely and P A Insel
      Molecular Pharmacology November 1982, 22 (3) 532-546;

  5. Souccar, C

    1. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;

  6. Stadel, J M

    1. Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;

  7. Statham, C N

    1. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;

  8. Steele, W J

    1. Mechanism of inhibition of protein synthesis by morphine in rat brain and liver.
      K C Retz and W J Steele
      Molecular Pharmacology November 1982, 22 (3) 706-714;

  9. Steinfelder, H J

    1. Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte.
      H G Joost and H J Steinfelder
      Molecular Pharmacology November 1982, 22 (3) 614-618;

  10. Stump, D C

    1. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
      D E Macfarlane and D C Stump
      Molecular Pharmacology November 1982, 22 (3) 574-579;

  11. Suen, E T

    1. Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
      E T Suen, P C Kwan and Y C Clement-Cormier
      Molecular Pharmacology November 1982, 22 (3) 595-601;

  12. Sufrin, J R

    1. Differences in the active-site region of tumor versus normal isozymes of mammalian ATP:L-methionine S-adenosyltransferase.
      J R Sufrin and J B Lombardini
      Molecular Pharmacology November 1982, 22 (3) 752-759;

T

  1. Tachizawa, H

    1. Rat liver microsomal metabolism of propyl halides.
      H Tachizawa, T L MacDonald and R A Neal
      Molecular Pharmacology November 1982, 22 (3) 745-751;

  2. Taylor, J W

    1. Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
      J W Taylor, R J Miller and E T Kaiser
      Molecular Pharmacology November 1982, 22 (3) 657-666;

  3. Tice, A J

    1. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
      J A Houghton, A J Tice and P J Houghton
      Molecular Pharmacology November 1982, 22 (3) 771-778;

  4. Tolkovsky, A M

    1. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
      A M Tolkovsky
      Molecular Pharmacology November 1982, 22 (3) 648-656;

  5. Trice, T B

    1. Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
      C Mottley, T B Trice and R P Mason
      Molecular Pharmacology November 1982, 22 (3) 732-737;

  6. Tukey, R H

    1. Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
      R H Tukey, M Negishi and D W Nebert
      Molecular Pharmacology November 1982, 22 (3) 779-786;

V

  1. Vale, R D

    1. Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;

  2. Vohra, M M

    1. Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.
      M M Vohra and P K Rautanen
      Molecular Pharmacology November 1982, 22 (3) 602-608;

W

  1. Warnick, J E

    1. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

  2. Williamson, L

    1. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;

  3. Willow, M

    1. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow and W A Catterall
      Molecular Pharmacology November 1982, 22 (3) 627-635;

  4. Wolf, C R

    1. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;

  5. Woodcock, E A

    1. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
      E A Woodcock and C I Johnston
      Molecular Pharmacology November 1982, 22 (3) 589-594;

Y

  1. Yoda, A

    1. Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 693-699;
    2. Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 700-705;

  2. Yoda, S

    1. Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 693-699;
    2. Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 700-705;
Back to top

In this issue

Advertisement